155 related articles for article (PubMed ID: 35342299)
1. Screening of Potential Key Biomarkers for Ewing Sarcoma: Evidence from Gene Array Analysis.
Zhong D; Chen D; Zhang G; Lin S; Mei R; Yu X
Int J Gen Med; 2022; 15():2575-2588. PubMed ID: 35342299
[TBL] [Abstract][Full Text] [Related]
2. Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma.
Deng Y; Xie Q; Zhang G; Li S; Wu Z; Ma Z; He X; Gao Y; Wang Y; Kang X; Wang J
Oncol Lett; 2019 Dec; 18(6):6431-6442. PubMed ID: 31807166
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel ubiquitination-related gene
Qu G; Xu Y; Qu Y; Qiu J; Chen G; Zhao N; Deng J
Front Oncol; 2023; 13():1000949. PubMed ID: 36910645
[TBL] [Abstract][Full Text] [Related]
4. Identification of key genes and pathways in Ewing's sarcoma using bioinformatics analysis.
Yan C; Wang Y; Wang Q; Feng X; Wang L; Bu Z; Lu B; Jiang J
J BUON; 2018; 23(5):1472-1480. PubMed ID: 30570875
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of Ewing's sarcoma: Seeking key candidate genes and pathways.
Zhang J; Zhang Y; Li Z; Wu H; Xun J; Feng H
Oncol Lett; 2019 Dec; 18(6):6008-6016. PubMed ID: 31788075
[TBL] [Abstract][Full Text] [Related]
6. Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing's sarcoma.
Shi X; Wu Y; Tang L; Ni H; Xu Y
Aging (Albany NY); 2023 Mar; 15(6):2321-2346. PubMed ID: 36988561
[TBL] [Abstract][Full Text] [Related]
7. Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma.
Liao H; Xie X; Xu Y; Huang G
Onco Targets Ther; 2018; 11():6947-6956. PubMed ID: 30410352
[TBL] [Abstract][Full Text] [Related]
8. Identification of key genes and pathways in Ewing's sarcoma patients associated with metastasis and poor prognosis.
Li G; Zhang P; Zhang W; Lei Z; He J; Meng J; Di T; Yan W
Onco Targets Ther; 2019; 12():4153-4165. PubMed ID: 31213834
[No Abstract] [Full Text] [Related]
9. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
10. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
11. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
13. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
14. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
Front Genet; 2020; 11():530892. PubMed ID: 33061942
[TBL] [Abstract][Full Text] [Related]
15. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
16. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
17. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
18. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
20. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
